Literature DB >> 31913320

Genetic predisposition for multiple myeloma.

Maroulio Pertesi1, Molly Went2, Markus Hansson1, Kari Hemminki3,4, Richard S Houlston2, Björn Nilsson5,6.   

Abstract

Multiple myeloma (MM) is the second most common blood malignancy. Epidemiological family studies going back to the 1920s have provided evidence for familial aggregation, suggesting a subset of cases have an inherited genetic background. Recently, studies aimed at explaining this phenomenon have begun to provide direct evidence for genetic predisposition to MM. Genome-wide association studies have identified common risk alleles at 24 independent loci. Sequencing studies of familial cases and kindreds have begun to identify promising candidate genes where variants with strong effects on MM risk might reside. Finally, functional studies are starting to give insight into how identified risk alleles promote the development of MM. Here, we review recent findings in MM predisposition field, and highlight open questions and future directions.

Entities:  

Mesh:

Year:  2020        PMID: 31913320     DOI: 10.1038/s41375-019-0703-6

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  72 in total

Review 1.  Effect of dietary protein on renal tubular clearance of drugs in humans.

Authors:  G D Park; R Spector; T M Kitt
Journal:  Clin Pharmacokinet       Date:  1989-12       Impact factor: 6.447

2.  Repression of transcription mediated at a thyroid hormone response element by the v-erb-A oncogene product.

Authors:  J Sap; A Muñoz; J Schmitt; H Stunnenberg; B Vennström
Journal:  Nature       Date:  1989-07-20       Impact factor: 49.962

3.  Clinical diversity of the Shy-Drager syndrome: a case in Hong Kong.

Authors:  S Lee; C N Chen
Journal:  J R Soc Med       Date:  1989-04       Impact factor: 5.344

4.  Pharmacy participation in nursing orientation programs.

Authors:  R M Fink; S W Jones
Journal:  Am J Hosp Pharm       Date:  1989-04

5.  The effects of monensin on the transport of horseradish peroxidase into intracellular lumina in cultured rat hepatocytes.

Authors:  I A Hashieh; L Rémy; S Mathieu; A Gérolami
Journal:  Hepatology       Date:  1989-07       Impact factor: 17.425

6.  Responses of the cerebellar auditory area to pure tone stimuli.

Authors:  J W Wolfe
Journal:  Exp Neurol       Date:  1972-08       Impact factor: 5.330

7.  [Karyological study of natural populations of malarial mosquitoes in the Middle Ob river. I. Characteristics of the karyotype of Anopheles maculipennis messeae].

Authors:  V M Kabanova; N N Kartashova; V N Stegniĭ
Journal:  Tsitologiia       Date:  1972-05

8.  Hypogonadism in chromatin-negative phenotypic male subjects.

Authors:  J P Donohue
Journal:  J Urol       Date:  1970-05       Impact factor: 7.450

9.  Cone mosaic observed directly through natural pupil of live vertebrate.

Authors:  M F Land; A W Snyder
Journal:  Vision Res       Date:  1985       Impact factor: 1.886

10.  The beta-carboline ZK 93423 inhibits reticulata neurons: an effect reversed by benzodiazepine antagonists.

Authors:  G Mereu; M G Corda; P Carcangiu; O Giorgi; G Biggio
Journal:  Life Sci       Date:  1987-04-06       Impact factor: 5.037

View more
  8 in total

1.  Characterization of rare germline variants in familial multiple myeloma.

Authors:  Calogerina Catalano; Nagarajan Paramasivam; Joanna Blocka; Sara Giangiobbe; Stefanie Huhn; Matthias Schlesner; Niels Weinhold; Rolf Sijmons; Mirjam de Jong; Christian Langer; Klaus-Dieter Preuss; Björn Nilsson; Brian Durie; Hartmut Goldschmidt; Obul Reddy Bandapalli; Kari Hemminki; Asta Försti
Journal:  Blood Cancer J       Date:  2021-02-13       Impact factor: 11.037

Review 2.  Protein Trafficking or Cell Signaling: A Dilemma for the Adaptor Protein TOM1.

Authors:  Tiffany G Roach; Heljä K M Lång; Wen Xiong; Samppa J Ryhänen; Daniel G S Capelluto
Journal:  Front Cell Dev Biol       Date:  2021-02-26

3.  Germline variants at SOHLH2 influence multiple myeloma risk.

Authors:  Laura Duran-Lozano; Gudmar Thorleifsson; Aitzkoa Lopez de Lapuente Portilla; Abhishek Niroula; Molly Went; Malte Thodberg; Maroulio Pertesi; Ram Ajore; Caterina Cafaro; Pall I Olason; Lilja Stefansdottir; G Bragi Walters; Gisli H Halldorsson; Ingemar Turesson; Martin F Kaiser; Niels Weinhold; Niels Abildgaard; Niels Frost Andersen; Ulf-Henrik Mellqvist; Anders Waage; Annette Juul-Vangsted; Unnur Thorsteinsdottir; Markus Hansson; Richard Houlston; Thorunn Rafnar; Kari Stefansson; Björn Nilsson
Journal:  Blood Cancer J       Date:  2021-04-19       Impact factor: 11.037

Review 4.  Genome Instability in Multiple Myeloma: Facts and Factors.

Authors:  Anna Y Aksenova; Anna S Zhuk; Artem G Lada; Irina V Zotova; Elena I Stepchenkova; Ivan I Kostroma; Sergey V Gritsaev; Youri I Pavlov
Journal:  Cancers (Basel)       Date:  2021-11-26       Impact factor: 6.639

Review 5.  Targeting Chemokine Receptor CCR1 as a Potential Therapeutic Approach for Multiple Myeloma.

Authors:  Annette Gilchrist; Stephanie L Echeverria
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-25       Impact factor: 5.555

6.  A polygenic risk score for multiple myeloma risk prediction.

Authors:  Federico Canzian; Chiara Piredda; Angelica Macauda; Daria Zawirska; Niels Frost Andersen; Arnon Nagler; Jan Maciej Zaucha; Grzegorz Mazur; Charles Dumontet; Marzena Wątek; Krzysztof Jamroziak; Juan Sainz; Judit Várkonyi; Aleksandra Butrym; Katia Beider; Niels Abildgaard; Fabienne Lesueur; Marek Dudziński; Annette Juul Vangsted; Matteo Pelosini; Edyta Subocz; Mario Petrini; Gabriele Buda; Małgorzata Raźny; Federica Gemignani; Herlander Marques; Enrico Orciuolo; Katalin Kadar; Artur Jurczyszyn; Agnieszka Druzd-Sitek; Ulla Vogel; Vibeke Andersen; Rui Manuel Reis; Anna Suska; Hervé Avet-Loiseau; Marcin Kruszewski; Waldemar Tomczak; Marcin Rymko; Stephane Minvielle; Daniele Campa
Journal:  Eur J Hum Genet       Date:  2021-11-30       Impact factor: 4.246

7.  Risk of multiple myeloma and other malignancies among first- and second-degree relatives of patients with multiple myeloma: A population-based study.

Authors:  Øystein O Langseth; Tor Å Myklebust; Tom B Johannesen; Øyvind Hjertner; Anders Waage
Journal:  Eur J Haematol       Date:  2022-03-07       Impact factor: 3.674

8.  Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes.

Authors:  Francesca Scionti; Giuseppe Agapito; Daniele Caracciolo; Caterina Riillo; Katia Grillone; Mario Cannataro; Maria Teresa Di Martino; Pierosandro Tagliaferri; Pierfrancesco Tassone; Mariamena Arbitrio
Journal:  Cells       Date:  2022-01-06       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.